Overview

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

Status:
Terminated
Trial end date:
2020-08-31
Target enrollment:
Participant gender:
Summary
This is an exploratory Phase 2 trial of BMX-010 in patients with Acne Vulgaris which will be conducted in two parts. Up to 210 subjects with Acne Vulgaris will be enrolled.
Phase:
Phase 2
Details
Lead Sponsor:
BioMimetix JV, LLC